Recombinant methionyl human stem cell factor and filgrastim for peripheral blood progenitor cell mobilization and transplantation in non- Hodgkin's lymphoma patients - Results of a phase I/II trial

Blood

Volumn 89, Issue 9, 1997, Pages 3136-3147

  Moskowitz, Craig H ^a   Stiff, Patrick ^b   Gordon, Michael S ^b   McNiece, Ian ^b   Ho, Anthony D ^b   Costa, John J ^b   Broun, E Randolf ^b   Bayer, Robert A ^b   Wyres, Melody ^b   Hill, Jerome ^b   Jelaca Maxwell, Kathy ^b   Nichols, Craig R ^b   Brown, Sherri L ^b   Nimer, Stephen D ^b   Gabrilove, Janice ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORMETHINE; CYTARABINE; MELPHALAN; NITROSOUREA DERIVATIVE; PROCARBAZINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT METHIONYL STEM CELL FACTOR; STEM CELL FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE MARROW TRANSPLANTATION; BURST FORMING UNIT; CELL DIFFERENTIATION; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; STEM CELL; THROMBOCYTE COUNT;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARMUSTINE; COLONY-FORMING UNITS ASSAY; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; ETOPOSIDE; FEMALE; FILGRASTIM; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKAPHERESIS; LEUKOCYTE COUNT; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; STEM CELL FACTOR;

EID: 0030906204     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Nadamanee A, Sniecinski I, Schmidt GM, Dagis AC, O'Donnell MR, Snyder DS, Parker PM, Stein AS, Smith EP, Molina A, Stepan DE, Somlo G, Margolin KA, Woo D, Niland JC, Foreman SJ: High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells. J Clin Oncol 12:2176, 1994
2. To LB, Shepperd KM, Haylock DN, Dyson PG, Charles P, Thorp DL, Dale BM, Dart GW, Roberts MM, Sage RE: Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood. Exp Hematol 18:442, 1990
3. Richman CM, Weiner RS, Yankee RA: Increasing circulating stem cells following chemotherapy in man. Blood 47:1031, 1976
4. Haas R, Ho AD, Bredthauer U, Cayeux S. Egerer G, Knauf W, Hunstein W: Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factor. Exp Hematol 18:94, 1990
5. Sheridan WP, Begley CG, Juttner CA, Szer J, To LB, Maher D, McGrath K, Morstyn G, Fox RM: Effect of peripheral-blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high dose chemotherapy. Lancet 339:640, 1992
6. Tarella C, Ferrero D, Bregni M, Siena S, Gallo E, Pileri A, Gianni AM: Peripheral blood expansion of early progenitor cells after high-dose cyclophosphamide and rhGM-CSF. Eur J Cancer 27:22, 1991
7. Ravignani F, Siena S, Bregni M, Sciorelli G, Gianni AM, Pellergris G: Large-scale collection of circulating haematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human GM-CSF. Eur J Cancer 26:562, 1990
8. Schmitz N, Linch DC, Dreger P, Goldstone AH, Boogaerts MA, Ferrant A, Demuynck HMS, Link H, Zander A, Barge A, Borkett K: Randomized trial of filgrastim-mobilized peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 347:353, 1996
9. Martin FH, Suggs SV, Langley KE, Lu HS, Ting J, Okiro KH, Morris CF, McNiece IK, Jacobsen FW, Mendiaz EA: Primary structure and functional expression of rat and human stem cell factor DNAs. Cell 63:203, 1990
10. Zsebo KM, Wypych J, McNiece IK, Lu HS, Smith KA, Karkare SB, Sachdev RK, Yuschenkoff VN, Birkett NC, Williams LR: Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver-conditioned medium. Cell 63:195, 1990
11. Anderson DM, Lyman SD, Baird A, Wignall JM, Risenman J, Rauch C, March CJ, Boswell HS, Gimpel SD, Cosman D: Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell 63:235, 1990
12. McNiece IK, Langley KE, Zsebo KM: Recombinant human stem cell factor synergizes with GM-CSF, G-CSF, IL-3 and Epo to stimulate human progenitor cells of the myeloid and erythroid lineages. Exp Hematol 19:226, 1991
13. - cells cultured with interleukin-3, granulocyte colony-stimulating factor, or granulocyte-macrophage colony-stimulating factor. Blood 77:2316, 1991
14. + anaplastic large cell lymphomas. Blood 83:785, 1994
15. Shui C, Khan WB, Leigh BR, Turner AM, Wilder RB, Knox SJ: Effects of stem cell factor on the growth and radiation survival of tumor cells. Cancer Res 55:3431, 1995
16. Molineux G, Migdalska A, Szmitkowski M, Zsebo K, Dexter TM: The effects on hematopoiesis of recombinant stem cell factor (ligand for c-kit) administered in vivo to mice either alone or in combination with granulocyte colony-stimulating factor. Blood 78:961, 1991
17. Schuening FG, Appelbaum FR, Deeg HJ, Sullivan PM, Graham TC, Hackman R, Zsebo KM, Storb R: Effects of recombinant canine stem cell factor, a c-kit ligand, and recombinant granulocyte colony-stimulating factor on hematopoietic recovery after otherwise lethal total-body irradiation. Blood 81:20, 1993
18. + colony-forming cell types in blood and marrow of baboons. Blood 80:920, 1992
19. Monroy RL, Ganey JT, Davis TA, Perrin PJ, Zsebo K, Stead R: Enhancement of hematopoietic recovery using recombinant human stem cell factor (SCF) after high dose chemotherapy in nonhuman primates. Exp Hematol 20:768, 1992 (abstr 242)
20. Briddell RA, Hartley CA, Smith KA, McNiece IK: Recombinant rat stem cell factor synergizes with recombinant human granulocyte colony-stimulating factor in vivo in mice to mobilize peripheral blood progenitor cells that have enhanced repopulating potential. Blood 82:1720, 1993
21. de Revel T, Appelbaum FR, Storb R, Schuening F, Nash R, Deeg J, McNiece I, Andrews R, Graham T: Effects of granulocyte colony-stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated dogs. Blood 83:3795, 1994
22. Andrews RG, Briddell RA, Knitter GH, Opie T, Bronsden M, Myerson D, Applebaum FR, McNiece I: In vivo synergy between recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in baboons: Enhanced circulation of progenitor cells. Blood 84:800, 1994
23. Crawford J, Lau D, Erwin R, Rich W, McGuire B, Meyers F: A phase I trial of recombinant methionyl human stem cell factor (SCF) in patients (pts) with advanced non-small cell lung carcinoma (NSCLC). Proc Am Soc Clin Oncol 112:135, 1993 (abstr 338)
24. Demetri G, Costa J, Hayes D, Sledge G, Galli S, Hoffman R, Merica E, Rich W, Harkins B, McGuire B, Gordon M: A phase I trial of recombinant methionyl human stem cell factor (SCF) in patients with advanced breast carcinoma pre- and post-chemotherapy (chemo) with cyclophosphamide (C) and doxorubicin (A). Proc Am Soc Clin Oncol 12:142, 1993 (abstr 367)
25. Breslow N: A generalized Kruskal Wallis Test for comparing K-samples subject to unequal patterns of censorship. Biometrika 57:579, 1970
26. Prince HM, Imrie K, Sutherland DR, Keating A, Meharchand J, Crump RM, Girouard C, Trip K, Stewart AK: Peripheral blood progenitor cell collections in multiple myeloma: Predictors and management of inadequate collections. Br J Haematol 93:142, 1996
27. . Tricot G, Jagannath S, Vesole D, Nelson J, Tindle S, Miller L, Cheson B, Crowley J, Barlogie B: Peripheral blood stem cell transplants from multiple myeloma: Identification of favorable variables for rapid engraftment in 225 patients. Blood 85:588, 1995
28. Olivieri A, Offidani M, Ciniero L, Poloni A, Masia M, Leoni P: Optimization of yield of PBSC for autotransplantation mobilized by high dose chemotherapy and G-CSF: Proposal for a mathematical model. Bone Marrow Transplant 14:273, 1994
29. Neben S, Hemman S, Montogemery M, Ferrar J, Mauch P: Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents. Exp Hematol 21:156, 1993
30. Botnick LE, Hannon EC, Hellman S: Nature of the hematopoietic stem cell compartment and its proliferation potential. Blood Cells 5:195, 1979
31. Haas R, Mohle R, Fruhauf S, Goldscmidt H, Witt B, Flenje M, Wannenbacher M, Hunstein W: Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 83:3787, 1994
32. Kotasek D, Shepherd KM, Sage RE, Dale BM, Norman JE, Gregg A, Pillow A, Bolton A: Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization patients with lymphoma, myeloma and solid tumors. Bone Marrow Transplant 9:11, 1992
33. Bensinger W, Applebaum F, Rowley S, Storb R, Sanders J, Lilleby K, Golley T, Demirer T, Schiffman K, Weaver C, Clift R, Chauncey T, Klarnet J, Montgomery P, Petersdorf S, Weiden P, Wotherspoon R, Buckner D: Factors that influence collection and engraftment of autologous peripheral blood stem cells. J Clin Oncol 13:2457, 1995
34. Dreger P, Kloss M, Petersen B, Haferlach T, Loffler H, Loeffler M, Schmitz N: Autologous Progenitor Cell Transplantation: Prior exposure to stem cell toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts. Blood 86:3970, 1995
35. Costa JJ, Demetri GD, Harrist PJ, Dvorak AM, Hayes DF, Merica EA, Menchaca DM, Gringeri AJ, Schwartz LB, Galli SJ: Recombinant human stem cell factor (c-kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J Exp Med 183:2681, 1996
36. Columbo M, Horowitz EM, Botana LM, MacGlashan DW, Boohner BS, Gillis S, Zsebo KM, Galli SJ, Lichtenstein LM: The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J Immunol 149:599, 1992
37. Langenmayer I, Weaver C, Buckner CD, Lilleby K, Appelbaum FR, Login K, Rowley S, Storb R, Singer J, Bensinger WI: Engraftment of patients with lymphoid malignancies transplanted with autologous bone marrow, peripheral blood stem cells or both. Bone Marrow Transplant 15:241, 1995
38. Sheridan WP, Begley CG, To LB, Grigg A, Szer J, Maher D, Greek MD, Rowlings PA, McGrath KM, Cebon J, Dyson P, Watson D, Bayly J, deLuca E, Tomita D, Huffman E, Morstyn G, Juttner CA, Fox RM: Phase II study of autologous filgrastim (G-CSF)-mobilized peripheral blood progenitor cells to restore hemopoiesis after high-dose chemotherapy for lymphoid malignancies. Bone Marrow Transplant 14:105, 1994
39. Bolwell BJ, Goormastic M, Yanssens T, Dannley R, Baucco P, Fishleder A: Comparison of G-CSF with GM-CSF for mobilizing peripheral blood progenitor cells and for enhancing marrow recovery after autologous bone marrow transplant. Bone Marrow Transplant 15:913, 1994